SL
SNY icon

Salomon & Ludwin’s Sanofi SNY Stock Holding History

Salomon & Ludwin’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$60.7K Sell
1,459
-238
-14% -$10.6K 0.01% 461
2026
Q1 		$81.3K Buy
1,697
+1,075
+173% +$50.1K 0.01% 303
2025
Q4 		$29.6K Sell
622
-146
-19% -$7.24K ﹤0.01% 621
2025
Q3 		$39.1K Buy
768
+701
+1,046% +$33.8K ﹤0.01% 449
2025
Q2 		$3.3K Buy
67
+27
+68% +$1.38K ﹤0.01% 604
2025
Q1 		$2.22K Hold
40
– – ﹤0.01% 581
2024
Q4 		$1.93K Hold
40
– – ﹤0.01% 597
2024
Q3 		$2.31K Hold
40
– – ﹤0.01% 602
2024
Q2 		$1.94K Sell
40
-79
-66% -$3.81K ﹤0.01% 609
2024
Q1 		$5.78K Hold
119
– – ﹤0.01% 615
2023
Q4 		$6.38K Hold
119
– – ﹤0.01% 553
2023
Q3 		$6.38K Buy
+119
New +$6.34K ﹤0.01% 551

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Salomon & Ludwin's SNY Position: Q2 2026 in Review

Salomon & Ludwin reduced its Sanofi (SNY) stake by 14% in Q2 2026, selling an estimated $10.6K and leaving 1,459 shares worth $60.7K. The position accounts for 0.01% of the portfolio, ranked #461.

Salomon & Ludwin first reported a position in SNY in Q3 2023 and has held it in 12 quarters since. The position peaked at $81.3K in Q1 2026. 717 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Salomon & Ludwin held 1,459 shares of Sanofi worth $60.7K as of Q2 2026.
  • Salomon & Ludwin sold 238 Sanofi shares in Q2 2026, an estimated $10.6K.
  • Sanofi made up 0.01% of Salomon & Ludwin's portfolio in Q2 2026, its #461 holding.
  • Salomon & Ludwin first reported a position in Sanofi in Q3 2023 and has held it in 12 quarters since.
  • Salomon & Ludwin's Sanofi position peaked at $81.3K in Q1 2026.
  • 717 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Salomon & Ludwin's 13F filing for Q2 2026, filed 7 Aug 2026.